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After earning his PhD with Jim Allison 
at the University of California, Berkeley, 
Max Krummel went down under to 
work with Ken Shortman and Bill Heath 
at the Walter and Eliza Hall Institute in 
Melbourne. But it wasn’t until his sec-
ond postdoc that Krummel cut his teeth 
on real-time microscopy while studying 
T cell signaling in Mark Davis’ laboratory 
at Stanford University (1). A year later he 
became a professor at the University of 
California, San Francisco, where his 
devotion to the approach has stuck.
Krummel describes images as quanti-
tative. As videos, they contain information 
in four dimensions including time. He has 
amended the technology to measure the 
speed of membrane receptor movement 
as antigen-presenting cells contact T 
lymphocytes (2), observed 
regulatory T cells inhibiting 
dendritic cell interactions (3), 
and visualized motor pro-
teins that modulate T cell 
migration (4, 5). Although 
he doesn’t intend for his 
vibrantly colored videos to 
look like art flicks—they are 
simply stunning.
SPACE & TIME
Neurobiologists and embryologists have been 
doing 4D live imaging studies for some 
time. Why was there a lag in immunology?
I think, in part, there was a lag because 
there is still so much being found out 
about these molecules. I mean, the T 
cell receptors and the B cell receptors 
are still a subject of intense scrutiny. 
Because this is so complex, it might 
have taken longer to realize that spatial 
dimensions play into decisions that the 
immune system makes, that there’s a 
bunch of diff  erent cell types, chemokines, 
and cytokines interacting in one micro-
environment. Now we’re getting to the 
phase where the question is how the 
immune system works in real space 
and time.
Have you faced any resistance from other 
immunologists when presenting an image 
rather than a quantitative chart or table?
Yes, I think people do have problems 
with that. It takes a re-appreciation of 
what an image is. Human eyes and brains 
are actually incredibly good at noticing 
quantitative information. We can see 
when something is a tad bit brighter or 
moving a little faster. At the back of the 
retina, individual pixels record how 
bright something is. A camera is nothing 
more than a spatial array of detectors. 
And so from that standpoint, there’s an 
infi   nitely large number of things that 
you can quantify in an image.
Still, there is a pushback in the field, 
which has been using certain techniques 
for a very long time to do things in vitro. 
Yet how cells behave in their native 
environment is so important. This is 
where the biochemistry takes place, so 
that’s where you have to meet it.
X-RAY SPECS
How can 4D imaging help us tackle 
diseases like cancer?
Historically, we’ve been working in a 
fl   at, two-dimensional space to look at 
cancer cell interactions. The way people 
study tumors and the T cell interaction 
in the tumors has just been to cut out a 
slice and see where cells are. But when 
you look over time, you realize that cells 
are behaving in groups. Sometimes 
those groups don’t spend much time 
together, but they consistently come 
back to each other. And you start to 
understand that it’s not two cell types 
talking to each other, but 50 diff  erent 
cell types, each of which has its own set 
of favorite cells to send information to.
This behavior can suggest why an 
immune response isn’t clearing a tumor. 
At some point, a tumor might subvert 
an interaction. So, if you can pick cell 
types that might be subverted, track 
them over time, and see who’ve they’ve 
been talking to, you can learn a lot.
How do you think tumors subvert T cells?
It may not be the tumor cells themselves. 
It could be other cell types in the tumor 
environment such as monocytes, B cells, 
NK cells, or even nontransformed epi-
thelial cells. We think that something 
must be happening to interfere with the 
T cells because if T cells are given antigen 
and are happily primed—especially CD8  +   
T cells—they will kill the target. And yet 
the reality of human cancer is that the 
T cells, even if primed, don’t kill the 
tumor.  And they do get primed, only 
somewhere along the way, they get turned 
off  . So the logical place to start looking 
for how that happens is in local tissues.
What has the two-photon microscope 
revealed about regulatory T (T reg) cells?
Visualization helps to answer questions 
about what T reg cells are doing. There 
exist 10 or 12 diff  erent models on how 
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these cells work. And the reality is that 
T reg cells are probably a collection of 
diff  erent kinds of cell types that work 
in diff  erent ways depending on the set-
ting. So the key is to fi  nd out how they 
work in a defi  ned setting. In our case, 
to understand autoimmune diabetes we 
looked at the lymph nodes of a diabetic 
mouse and asked how the T reg cells 
were preventing eff   ector cells from 
getting activated (3).
In those studies, two things became 
clear. The first thing was that T reg 
cells weren’t physically capturing or 
sequestering T cells through some kind 
of stable interaction—there just wasn’t 
evidence for this. And the second was 
that while T reg cells efficiently inter-
acted with antigen-bearing dendritic 
cells, their presence dramatically pre-
vented interactions of helper cells with 
those same putative antigen-presenting 
cells. So, there has emerged strong support 
for a model in which T reg cells physically 
alter either the dendritic cells or the 
microenvironment in which they live.
What are you doing on sabbatical now?
I’m working at the Institut Curie in 
Paris with a friend of mine, Sebastian 
Amigorena. Although a lot of things in 
his group are fundamentally the same, the 
environment is totally diff  erent. At UCSF, 
my neighbors are almost all immunolo-
gists; at the Curie, there are a lot of 
biophysicists working on the role of 
force, rigidity, and structure. These 
aspects come into play when we start to 
look at the immune responses in diff  erent 
organs and tissues because the design of 
the organ matters. That’s one of the 
things that I didn’t necessarily think I 
would be thinking about, but now I am. 
In order to look at cell motility, I’m using 
photomasks from microchip fabrication 
to pour molds of structures that cells must 
navigate. I’m also trying to develop some 
stromal cell line cultures to examine the 
role of the stroma in T cell activation.
If a leprechaun granted you the microscope 
of your wildest dreams, what could it do?
I think the ultimate thing would be to have 
down-to-the-nanometer scale resolution 
of everything in three dimensions over 
time. And, I mean, if I’ve got a leprechaun, 
then I’d want to complement the micro-
scope with a technology that allows you to 
perturb things while observing them.
STRIKING A BALANCE
When you were in graduate school at 
Berkeley, did you live in the infamously 
wild co-ops?
No, actually I had a funny gig at Berkeley 
where I was a houseboy for two of the 
fi   rst psychotherapists to 
set up a clinic in Berkeley. 
It was like the fi  rst taco 
stand in Mexico… It was 
a giant mansion right at 
the base of the Clare-
mont Hotel. I trimmed 
the hedges, walked the 
dog, and did other chores 
in exchange for rent. 
The cool thing about 
doing it was that it forced 
me to have a balanced 
life; I had to go home as 
part of my job.
Has your technique as a 
P .I. changed since you 
became a 33-year-old 
assistant professor?
Yes, a little bit. A strange thing happens 
when you become a P.I. The day before 
you become faculty, you can walk around 
your old laboratory, and people take 
your opinions as just another opinion. 
But the minute you become a P.I., when 
you spout an opinion, everyone acts on 
it. So there’s this complete change purely 
because of the title you now have. And 
so I learned that, my rela-
tionships with people had 
to evolve.
One of the best for-
mulations I’ve come up 
with in the last two years 
is really to give people a 
sense of their own. I’m not 
watching over them quite 
as much as I did in the first 
five years. If people think 
their career is in their own 
hands, then they act more 
like their career is in their 
own hands.
Besides the science, are you enticed by 
simply creating beautiful images?
I very much like the aesthetic aspect of 
it. It’s a nice fi  eld to be in because it hu-
manizes the sciences. Other scientists 
might trivialize an image and say, “Yeah, 
nice photo,” and not think that it’s quan-
titative. But at the other end of the spec-
trum, if you have a nonscientist look at 
it, they say, “Beautiful, I can’t believe 
that’s going on in my lymph node!” You 
tend to blow people’s minds with this 
kind of stuff  . If you show a layperson a 
gel, they have no idea what it means. 
Compare that to showing them videos 
and saying, “These are the cells trying to 
clear a tumor.”
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CD4  +   T cells (green) and CD8  +   T cells (red) mingle among 
collagen fibers (blue) in a living lymph node.
“If you can 








to, you can 
learn a lot.”